miR-101-3p was reduced in InsR+/− hepatocytes and HSCs and even more in InsR+/− cells exposed to insulin (0.33 μM) and fatty acids (0.25 mM), resembling the IR-NASH model. The gene discussed is INSR; the disease is metabolic dysfunction-associated steatohepatitis.